NovioGendix's Series A Round

NovioGendix raised a round of funding on January 21, 2008.

NovioGendix is a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer.…

Articles about NovioGendix's Series A Round: